Arnaud Bosquet

Partner at Fremman Capital | Head of the Paris Office

📍 London, England Metropolitan Area, United Kingdom🔄 Updated September 2026💼 4 investments📅 14 years investing🗓 Last invested Jul 2017
VC🌍 United Kingdom
4
Total investments
0
Early stage
0
Mid stage
0
Late stage
14y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Sep 2016
Neuraxpharm is the leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has more than 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira. Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com
Board Member
Oct 2012
Capio – Nordens största privata vårdgivare Capios vision är att förbättra hälsan för människor varje dag. Vi vill göra skillnad för våra patienter genom att se, lyssna och finnas här – idag och genom hela livet. Våra medarbetare är viktiga för oss och vi vill ge dem kraften att finnas där för våra patienter men också för att utveckla vården i stort. I vårt dagliga arbete jobbar vi utifrån våra värderingar: Quality, Empowerment, Innovation och Social responsibility. De hjälper oss att uppfylla vårt patientlöfte om att vara en pålitlig partner – närvarande och nytänkande. Tillsammans förbättrar vi folkhälsan – en individ i taget! Capio erbjuder ett brett och högkvalitativt vårdutbud genom våra sjukhus, specialistkliniker och vårdcentraler i Sverige, Norge och Danmark. Våra patienter kan även få hjälp via våra digitala tjänster. Capio är sedan 2018 en del av Ramsay Santé - en ledande vårdgivare med 36 000 medarbetare i sex länder. För mer information, besök capio.se.
Experience · 6 entries
All (6)
Investments (4)
Board (4)
2026
Partner, Head of the Paris Office
Jun 2026
Fremman is an independent Pan European Private Equity firm, with offices in London, Madrid, Munich, Paris, Milan and Luxembourg. We Value Values - Our senior team has worked together for years and generated superior returns, employing a proactive and empathetic approach. They are supported by a team of like-minded professionals, focused on partnering with ambitious management teams and investing responsibly.
2017
Board Member
Jul 2017
Candela’s brand values of Science, Results, and Trust guide its commitment to safety, efficacy, reliability and strengthening the longstanding partnerships of trust established with physicians, their practices and the patients they treat. Established in 1970, Candela is a leading US-based global medical aesthetic device company with headquarters in Wayland, Massachusetts. The company's technologies enable physicians to provide advanced energy-based solutions for a broad range of medical-aesthetic applications including benign vascular and pigmented lesions, scars, hair removal, facial resurfacing, wrinkle reduction, women's health treatments, tattoo removal, acne, leg veins, cellulite, and body shaping.
2016
Board Member
Sep 2016
Neuraxpharm is the leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has more than 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira. Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com
2012
Board Member
Oct 2012
Capio – Nordens största privata vårdgivare Capios vision är att förbättra hälsan för människor varje dag. Vi vill göra skillnad för våra patienter genom att se, lyssna och finnas här – idag och genom hela livet. Våra medarbetare är viktiga för oss och vi vill ge dem kraften att finnas där för våra patienter men också för att utveckla vården i stort. I vårt dagliga arbete jobbar vi utifrån våra värderingar: Quality, Empowerment, Innovation och Social responsibility. De hjälper oss att uppfylla vårt patientlöfte om att vara en pålitlig partner – närvarande och nytänkande. Tillsammans förbättrar vi folkhälsan – en individ i taget! Capio erbjuder ett brett och högkvalitativt vårdutbud genom våra sjukhus, specialistkliniker och vårdcentraler i Sverige, Norge och Danmark. Våra patienter kan även få hjälp via våra digitala tjänster. Capio är sedan 2018 en del av Ramsay Santé - en ledande vårdgivare med 36 000 medarbetare i sex länder. För mer information, besök capio.se.
Capio
Board Member
Oct 2012
Show all 6 entries ↓
Investment activity
2012–2017 · 4 investments
201222016120171
Recent (last 2 years)Earlier